当前位置: 首页 > 期刊 > 《中国医药科学》 > 2012年第3期
编号:13183345
多发性骨髓瘤并发静脉血栓的研究进展(1)
http://www.100md.com 2012年2月1日 《中国医药科学》 2012年第3期
     [摘要] 多发性骨髓瘤是源于浆细胞的恶性肿瘤,易发生静脉血栓栓塞。多发性骨髓瘤患者血液的高凝状态、年龄、静脉血栓栓塞病史、肥胖、合并疾病以及中心静脉置管、免疫调节剂及化疗药物的应用均使静脉血栓栓塞的危险性增加。研究表明,多发性骨髓瘤患者治疗时采取抗凝药物等预防血栓措施可有效降低静脉血栓栓塞的发生率。

    [关键词] 骨髓瘤;血栓,静脉;预防

    [中图分类号] R733.3 [文献标识码] A [文章编号] 2095-0616(2012)03-

    Venous Thromboembolism Complications in Multiple Myeloma

    LV Zhenhui MENG Zhaosheng

    Department of Hematology,Zibo Center Hospital of Shandong Province,Zibo 255036,China

    [Abstract] Multiple myeloma is a m alignant tumor derived from plasmacytoid lymphocyte.An increased risk of VTE may occur in patients with multiple myeloma. The risk factors for VTE are high fixed state of blood,age,history of VTE,obesity,complications,centralvenous catheter,therapy with immune adjustment drug or multidrug chemotherapy. A study shows that incidence of VTE may decrease after prevention by receiving prophylaxis of venous thrombosis during treatment with drugs.

    [Key words] Myeloma;Venous Thromboembolism;Prevention

    多发性骨髓瘤(multiple myeloma ......
1 2下一页

您现在查看是摘要页,全文长 5705 字符